XML 39 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Note 15 - Stock-based Compensation
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Note 15. Stock-Based Compensation

The Company’s Board of Directors adopted in January 2008, and the stockholders approved in May 2008, the QCR Holdings, Inc. 2008 Equity Incentive Plan (“2008 Equity Incentive Plan”). The Company’s Board of Directors adopted in February 2010, and the stockholders approved in May 2010, the QCR Holdings, Inc. 2010 Equity Incentive Plan (“2010 Equity Incentive Plan”). The Company’s Board of Directors adopted in February 2013, and the stockholders approved in May 2013, the QCR Holdings, Inc. 2013 Equity Incentive Plan (“2013 Equity Incentive Plan”). The Company’s Board of Directors adopted in February 2016, and the stockholders approved in May 2016, the QCR Holdings, Inc. 2016 Equity Incentive Plan (“2016 Equity Incentive Plan”). Up to 250,000,  350,000,  350,000, and 400,000 shares of common stock, respectively, may be issued to employees and directors of the Company and its subsidiaries pursuant to equity incentive awards granted under these plans.

The 2008 Equity Incentive Plan, the 2010 Equity Incentive Plan, the 2013 Equity Incentive Plan, and the 2016 Equity Incentive Plan (collectively, the “Stock Option Plans”) are administered by the Compensation Committee of the Board of Directors (the “Committee”). As of December 31, 2018, there were 302,066 remaining shares of common stock available for grant under the Stock Option Plans; however, such additional shares may be issued only under the 2016 Equity Incentive Plan.

The number and exercise price of options granted under the stock option plans are determined by the Committee at the time the option is granted. In no event can the exercise price be less than the value of the common stock at the date of the grant for stock options. All options have a 10‑year life and will vest and become exercisable from 3‑to‑7 years after the date of the grant.

Stock-based compensation expense was reflected in the Consolidated Financial Statements as follows for the years ended December 31, 2018, 2017, and 2016.

 

 

 

 

 

 

 

 

 

 

 

    

2018

    

2017

    

2016

Stock options

 

$

471,849

 

$

554,435

 

$

424,904

Restricted stock awards

 

 

856,731

 

 

552,907

 

 

460,853

Stock purchase plan

 

 

114,766

 

 

79,694

 

 

61,417

 

 

$

1,443,346

 

$

1,187,036

 

$

947,174

 

Note 15. Stock-Based Compensastion (continued)

Stock options:

A summary of the stock option plans as of December 31, 2018, 2017, and 2016 and changes during the years then ended is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 

 

 

2018

 

2017

 

2016

 

 

 

 

 

Weighted

 

 

 

 

Weighted

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

Average

 

 

 

 

Average

 

 

 

 

 

Exercise

 

 

 

 

Exercise

 

 

 

 

Exercise

 

    

Shares

    

Price

    

Shares

    

Price

    

Shares

    

Price

Outstanding, beginning

 

 

513,554

 

$

17.13

 

 

587,961

 

$

14.83

 

 

623,176

 

$

13.88

Granted

 

 

16,315

 

 

44.02

 

 

43,250

 

 

43.86

 

 

76,749

 

 

22.92

Exercised

 

 

(60,127)

 

 

13.56

 

 

(114,100)

 

 

15.12

 

 

(111,423)

 

 

14.97

Forfeited

 

 

(170)

 

 

16.81

 

 

(3,557)

 

 

26.74

 

 

(541)

 

 

18.36

Outstanding, ending

 

 

469,572

 

 

18.52

 

 

513,554

 

 

17.13

 

 

587,961

 

 

14.83

 

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

Exercisable, ending

 

 

358,270

 

 

  

 

 

354,269

 

 

  

 

 

385,372

 

 

  

 

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

Weighted average fair value per option granted

 

$

14.68

 

 

  

 

$

14.75

 

 

  

 

$

7.31

 

 

  

 

A further summary of options outstanding as of December 31, 2018 is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Options Exercisable

 

 

 

 

Average

 

Weighted

 

 

 

Weighted

 

 

 

 

Remaining

 

Average

 

 

 

Average

Range of

 

Number

 

Contractual

 

Exercise

 

Number

 

Exercise

Exercise Prices

    

Outstanding

    

Life

    

Price

    

Exercisable

    

Price

$7.99 to $8.93

 

24,175

 

2.07

 

$

8.10

 

24,175

 

$

8.10

$9.00 to $9.30

 

121,724

 

2.10

 

 

9.21

 

121,724

 

 

9.21

$15.08 to $16.13

 

74,703

 

4.24

 

 

15.63

 

72,303

 

 

15.64

$17.10 to $18.00

 

125,137

 

5.56

 

 

17.31

 

99,573

 

 

17.29

$21.71 to $31.53

 

66,291

 

7.11

 

 

22.92

 

29,633

 

 

22.64

$42.65 to $48.50

 

57,542

 

8.46

 

 

43.94

 

10,862

 

 

43.79

 

 

469,572

 

  

 

 

  

 

358,270

 

 

  

 

Restricted stock awards:

A summary of changes in the Company’s nonvested restricted stock awards as of December 31, 2018, 2017 and 2016 is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 

 

    

2018

    

2017

    

2016

Outstanding, beginning

 

 

46,389

 

 

39,438

 

 

45,046

Granted*

 

 

37,315

 

 

28,289

 

 

22,382

Released

 

 

(19,605)

 

 

(21,338)

 

 

(27,490)

Forfeited

 

 

 —

 

 

 —

 

 

(500)

Outstanding, ending

 

 

64,099

 

 

46,389

 

 

39,438

 

 

 

 

 

 

 

 

 

 

Weighted average fair value per share granted

 

$

43.50

 

$

44.44

 

$

22.64

 

*  Includes 22,660 of restricted stock awards and 14,655 of restricted stock units.

The total grant value of restricted stock awards that were released during the years ended December 31, 2018, 2017 and 2016 was $622 thousand, $509 thousand and $474 thousand, respectively.

Note 15. Stock-Based Compensation (continued):

Stock purchase plan:

The Company’s Board of Directors and its stockholders adopted in October 2002 the QCR Holdings, Inc. Employee Stock Purchase Plan (the “Purchase Plan”). On May 2, 2012, the Company’s stockholders approved a complete amendment and restatement of the Purchase Plan. As of January 1, 2018, there were 175,507 shares of common stock available for issuance under the Purchase Plan. For each six-month offering period, the Board of Directors will determine how many of the total number of available shares will be offered. The purchase price is the lesser of 85% of the fair market value at the date of the grant or the investment date. The investment date, as established by the Board of Directors, is the date common stock is purchased after the end of each calendar quarter during an offering period. The maximum dollar amount any one participant can elect to contribute in an offering period is $10,000. Additionally, the maximum percentage that any one participant can elect to contribute is 10% of his or her compensation for the year ended December 31, 2018 and 2017 and 8% for the year ended December 31, 2016. Information for the stock purchase plan for the years ended December 31, 2018, 2017, and 2016 is presented below:

 

 

 

 

 

 

 

 

 

 

 

    

2018

    

2017

    

2016

Shares granted

 

 

17,305

 

 

12,414

 

 

18,711

Shares purchased

 

 

15,528

 

 

13,318

 

 

20,192

Weighted average fair value per share granted

 

$

6.63

 

$

6.42

 

$

3.28